Search

You searched for "Consent"

3065 results found

Aflibercept treatment in polypoidal choroidal vasculopathy

1 April 2019 | | EYE - Vitreo-Retinal
The authors present a study to evaluate the anatomical and functional efficacy of aflibercept intravitreal (IVT) as a monotherapy in polypoidal choroidal vasculopathy (PCV) in a Caucasian population treated with initial three-monthly aflibercept IVT, followed by a bimonthly regimen for...
Ophthalmologica journal cover image

Sickle cell maculopathy

1 October 2021 | | EYE - Vitreo-Retinal | OCT imaging, Sickle cell disease, Sickle cell maculopathy, Visual impairment
This paper reports the result of a prospective study to analyse the prevalence of sickle cell maculopathy (SCM) and its associations with age, sex, genotype, proliferative sickle cell retinopathy (PSR) stage, and the impact on visual acuity (VA). This study...

Glaucoma UK announces winners of the 2025 ‘Excellence in Glaucoma Care Award’

27 March 2025 | Glaucoma UK, Annoucement, Winners 2025, Excellence in Glaucoma Care Award, optometrist, optometry
Glaucoma UK is delighted to announce the winners of this year's Excellence in Glaucoma Care Awards – Patrick (Paddy) Gunn from Manchester and Alex Gage Family Optometrists in Sheffield. This annual award celebrates individuals or teams who have made remarkable...

Protecting retinal ganglion cells

1 August 2017 | | EYE - Glaucoma
Glaucoma is considered to be a heterogeneous group of conditions giving retinal ganglion cells (RGC) damage. Lowering intraocular pressure (IOP) reduces the risk of progressive RGC loss in glaucoma. Regeneration of the optic nerve has been shown to restore some...

Blind astrophysicist inspires next generation

2 May 2025 | Haggeye, patient stories, science, TED Talk, Wanda Díaz-Merced, physics
Eilidh Morrison (23), a physics graduate from Aberdeen and Member of the Scottish Youth Parliament (MSYP) was starstruck last month when she met her long-time inspiration, blind astrophysicist Dr Wanda Díaz-Merced. Born with Joubert Syndrome, a rare condition that includes...

Learning to see the bigger picture: Reflections from a cataract surgery course in the Middle East

5 June 2025 | | EYE - Cataract
Alcon, the Swiss-American company specialising in eyecare equipment, inaugurated their Alcon Experience Centre (AEC) in Jeddah, Saudi Arabia. AEC is an eye education and training centre for students and eyecare professionals. This is the first AEC catering to the Middle...

Conor Lavery promoted to Glaukos National Field Sales Manager, UK and Ireland

4 May 2023 | Recruitment & Personnel
Glaukos is delighted to announce the promotion of Conor Lavery to National Field Sales Manager UK & Ireland, in his new role he will manage the Sales teams in these counties and provide support to Northern Europe management.

Simon Lysaght joins Glaukos as Territory Manager, Ireland

28 June 2023 | Recruitment & Personnel
Glaukos Corporation is delighted to announce the appointment of Simon Lysaght to the position of Territory Manager, Ireland.

Darren Hargreaves joins Sense Medical as Clinical Solutions Director

26 July 2023 | Recruitment & Personnel
Sense Medical Ltd welcomes the new appointment of Darren Hargreaves as Clinical Solutions Director.

Graham Popham joins Glaukos as Senior Director, Market Access EMEAI

11 December 2025 | Recruitment & Personnel
Glaukos are delighted to announce the appointment of Graham Popham as Senior Director, Market Access EMEAI. Graham comments: "’I'm excited to join Glaukos at such a pivotal time in the evolution of ophthalmic care and growth of the organisation. Throughout...

Move for ABDO College Principal

9 November 2023 | Robert Cubbidge, Clive Marchant, ABDO College
ABDO College Principal Dr Robert Cubbidge is to move on from his current role and focus on optometry and his academic interests.

The Eye Care Support Pathway from RNIB

20 November 2023 | RNIB, Eye Care Support Pathway, #eyecaresupportpathway, patient care
The #EyeCareSupportPathway is a framework, developed by RNIB and partners across the sector, for the NHS, social care organisations, the third sector and the public to use to support the transformation of eye care and eye services.